Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis-Reference-Cited by-同舟云学术

Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis

Published:1996 Issue:4 Volume:381 Page:225-227
ISSN:0023-8236
Container-title:Langenbecks Archiv f�r Chirurgie
language:en
Short-container-title:Langenbecks Arch Chiv

Author:

Schwab G. P.,Wetscher G. J.,Vogl W.,Redmond E.

Publisher

Springer Science and Business Media LLC

Subject

Surgery,Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF00571690.pdf

Reference18 articles.

1. Stanley MM, Astwood EB (1949)1-Methyl-mercaptoimidazole: an antithyroid compound highly active in man. Endocrinology 44:588?589

2. BarthelsEC (1953) Clinical experience with a new antithyroid drug: 2-carbebethoxylthio-l-methylglyoxaline. J Clin Endocrin 12:1305?1311

3. Becker CE, Gordon P, Robbins J (1968) Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmus. JAMA 206:1787?1789

4. Efstratiadis N, Holzberg R, Schmidt W, Teuber G, Wildhirt E (1982) Toxische cholestatische Hepatose durch Thiamazol und Carbimazol. Dtsch Med Wochenschr 107:1531?1533

5. Fischer MG, Nayer HR, Miller A (1973) Methimazole-induced jaundice. JAMA 223:1028?1029

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging;Endoscopic Ultrasound;2023

2. Long-term sequelae of drug-induced liver injury;Journal of Hepatology;2022-02

3. Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity;Chemical Research in Toxicology;2021-11-17

4. Drug-Induced Cholangiopathies;Diseases of the Liver and Biliary Tree;2021

5. A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?;International Journal of Endocrinology and Metabolism;2020-10-31